Abstract:CellFinder (http://www.cellfinder.org) is a comprehensive one-stop resource for molecular data characterizing mammalian cells in different tissues and in different development stages. It is built from carefully selected data sets stemming from other curated databases and the biomedical literature. To date, CellFinder describes 3394 cell types and 50 951 cell lines. The database currently contains 3055 microscopic and anatomical images, 205 whole-genome expression profiles of 194 cell/tissue types from RNA-seq … Show more
“…Transcriptome data was collected from published 13 of 24 Figure 1A and a complete list of all samples is given in Supplementary Data S1. Samples were manually annotated for their tissue origin and cell types using ontology terms (Malone et al, 2010;Stachelscheid et al, 2014). Raw microarray data were obtained from the public repositories Gene Expression Omnibus and ArrayExpress (Barrett et al, 2009;Rustici et al, 2013).…”
SummaryInduced pluripotent stem cells (iPS) and direct lineage programming offer promising autologous and patient-specific sources of cells for personalized drug-testing and cellbased therapy. Before these engineered cells can be widely used, it is important to evaluate how well the engineered cell types resemble their intended target cell types.We have developed a method to generate CellScore, a cell identity score that can be used to evaluate the success of an engineered cell type in relation to both its initial and desired target cell type, which are used as references. Of 20 cell transitions tested, the most successful transitions were the iPS cells (CellScore > 0.9), while other transitions (e.g. induced hepatocytes or motor neurons) indicated incomplete transitions (CellScore < 0.5). In principle, the method can be applied to any engineered cell undergoing a cell transition, where transcription profiles are available for the reference cell types and the engineered cell type.
Highlights• A curated standard dataset of transcription profiles from normal cell types was created.• CellScore evaluates the cell identity of engineered cell types, using the curated dataset.• CellScore considers the initial and desired target cell type.• CellScore identifies the most successfully engineered clones for further functional testing.
“…Transcriptome data was collected from published 13 of 24 Figure 1A and a complete list of all samples is given in Supplementary Data S1. Samples were manually annotated for their tissue origin and cell types using ontology terms (Malone et al, 2010;Stachelscheid et al, 2014). Raw microarray data were obtained from the public repositories Gene Expression Omnibus and ArrayExpress (Barrett et al, 2009;Rustici et al, 2013).…”
SummaryInduced pluripotent stem cells (iPS) and direct lineage programming offer promising autologous and patient-specific sources of cells for personalized drug-testing and cellbased therapy. Before these engineered cells can be widely used, it is important to evaluate how well the engineered cell types resemble their intended target cell types.We have developed a method to generate CellScore, a cell identity score that can be used to evaluate the success of an engineered cell type in relation to both its initial and desired target cell type, which are used as references. Of 20 cell transitions tested, the most successful transitions were the iPS cells (CellScore > 0.9), while other transitions (e.g. induced hepatocytes or motor neurons) indicated incomplete transitions (CellScore < 0.5). In principle, the method can be applied to any engineered cell undergoing a cell transition, where transcription profiles are available for the reference cell types and the engineered cell type.
Highlights• A curated standard dataset of transcription profiles from normal cell types was created.• CellScore evaluates the cell identity of engineered cell types, using the curated dataset.• CellScore considers the initial and desired target cell type.• CellScore identifies the most successfully engineered clones for further functional testing.
“…Such depth of characterization is also necessary to unambiguously classify hiPSC-derived renal cell types by comparing these cells to their native equivalents. Technological tools are now available to characterize cells on the single-cell level and to analyze the associated data [34]. At the BCRT, we have developed a registry of cell type-associated data as a first step to characterize most or all distinct cell types of the kidney and other organs (Fig.…”
Section: Innovative Approaches To Disease Modeling and Outcome Predicmentioning
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of systemic autoimmune disorders characterized by necrotizing inflammation of medium-to-small vessels, a relative paucity of immune deposits, and an association with detectable circulating ANCAs. AAVs include granulomatosis with polyangiitis (renamed from Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Until recently, AAVs have not been viewed as complement-mediated disorders. However, recent findings predominantly from animal studies demonstrated a crucial role of the complement system in the pathogenesis of AAVs. Complement activation or defects in its regulation have been described in an increasing number of acquired or genetically driven forms of thrombotic microangiopathy. Coinciding with this expanding spectrum of complement-mediated diseases, the question arises as to which AAV patients might benefit from a complement-targeted therapy. Therapies directed against the complement system point to the necessity of a genetic workup of genes of complement components and regulators in patients with AAV. Genetic testing together with pluripotent stem cells and bioinformatics tools may broaden our approach to the treatment of patients with aggressive forms of AAV.
“…This includes an online registration tool and expanded options for registration of ethical, scientifi c, and quality data as well as uploading of documents such as protocols, and ethical and regulatory documentation. The provision of easy browsing of cell -and project -related information for registered cell lines in hESCreg also requires the development of new technical solutions such as semantic search algorithms and ontology -based data organization [11].…”
Section: Ebisc: the First European Bank For Induced Pluripotent Stem mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.